Molecular Imprints Completes $17M Financing

Molecular Imprints, Inc. (MII, Austin, TX) has raised $17 million in the first closing of a planned $25 million Series C financing. Molecular Imprints will use the money to expand its Imprio® product line. To date, MII has raised over $60M in funding.

Investors participating in this financing include Dai Nippon Printing Company (DNP), Alloy Ventures, Motorola Ventures, Harris & Harris, Draper Fisher Jurvetson, Hakuto Co. Ltd., Asset Management Partners and others.

Dr. Norm Schumaker, MII’s CEO, says, “Molecular Imprints appreciates the support and vote of confidence our investor base is expressing with this new round of financing. We are committed to delivering on our mission of enabling nanoscale manufacturing in markets such as nano-devices, LEDs for solid state lighting, magnetic data storage for micro disk drives, and others. We are pleased to have DNP, a major supplier of photomasks, join a growing number of world class suppliers who are investing in the technology required to support the commercialization of MII’s S-FIL™ imprint lithography. DNP’s technical leadership, along with the other photomask manufacturers that MII is working with, will help further increase the availability of advanced imprint templates, a key element of the imprint process.”

Visit www.molecularimprints.com